Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dutkiewicz

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1996
Doxazosin-alpha-1-adrenergic antagonists drug in the long-term (3 years). Management of benign prostatic hyperplasiaS Dutkiewicz
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1995
Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapyS Dutkiewicz
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|February 1, 1996
[Pharmacologic treatment of mild proliferation of prostatic cancer]S Dutkiewicz
International Urology and Nephrology|January 1, 1996
Usefulness of Cernilton in the treatment of benign prostatic hyperplasiaS Dutkiewicz
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|June 15, 1992
[Palliative methods of the treatment of prostatic adenoma]S Dutkiewicz
International Urology and Nephrology|January 1, 1994
Posterior urethral valves in an adult male. A case reportS Dutkiewicz
International Urology and Nephrology|January 1, 1994
Renal oncocytoma. A rare entity in PolandS Dutkiewicz
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1995
A comparative study of: long-term alpha-1-blocker, Doxazosin therapy versus surgery in the treatment of benign prostatic hyperplasiaS Dutkiewicz
International Urology and Nephrology|January 1, 1995
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part One)S Dutkiewicz, A Witeska
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|April 1, 1996
Serum PSA levels at 6 month after surgery, TURP or Doxazosin therapy for BPHS Dutkiewicz, K Stepień
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1996
Doxazosin-alpha-1-adrenergic antagonists drug in the long-term (3 years). Management of benign prostatic hyperplasiaS Dutkiewicz
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|January 1, 1995
Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapyS Dutkiewicz
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|February 1, 1996
[Pharmacologic treatment of mild proliferation of prostatic cancer]S Dutkiewicz
International Urology and Nephrology|January 1, 1996
Usefulness of Cernilton in the treatment of benign prostatic hyperplasiaS Dutkiewicz
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|June 15, 1992
[Palliative methods of the treatment of prostatic adenoma]S Dutkiewicz
International Urology and Nephrology|January 1, 1994
Posterior urethral valves in an adult male. A case reportS Dutkiewicz
International Urology and Nephrology|January 1, 1994
Renal oncocytoma. A rare entity in PolandS Dutkiewicz
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1995
A comparative study of: long-term alpha-1-blocker, Doxazosin therapy versus surgery in the treatment of benign prostatic hyperplasiaS Dutkiewicz
International Urology and Nephrology|January 1, 1995
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part One)S Dutkiewicz, A Witeska
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|April 1, 1996
Serum PSA levels at 6 month after surgery, TURP or Doxazosin therapy for BPHS Dutkiewicz, K Stepień
Pageof 4